【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Pulmonary Fibrosis Overview 10
Therapeutics Development 11
Pipeline Products for Pulmonary Fibrosis – Overview 11
Pipeline Products for Pulmonary Fibrosis – Comparative Analysis 12
Pulmonary Fibrosis – Therapeutics under Development by Companies 13
Pulmonary Fibrosis – Therapeutics under Investigation by Universities/Institutes 19
Pulmonary Fibrosis – Pipeline Products Glance 20
Late Stage Products 20
Clinical Stage Products 21
Early Stage Products 22
Unknown Stage Products 23
Pulmonary Fibrosis – Products under Development by Companies 24
Pulmonary Fibrosis – Products under Investigation by Universities/Institutes 30
Pulmonary Fibrosis – Companies Involved in Therapeutics Development 31
AdAlta Pty Ltd. 31
Aeolus Pharmaceuticals, Inc. 32
AnaptysBio, Inc. 33
Angion Biomedica Corp. 34
Aquinox Pharmaceuticals Inc. 35
Auspex Pharmaceuticals, Inc. 36
Biogen Idec Inc. 37
BiOrion Technologies B.V. 38
Boehringer Ingelheim GmbH 39
Bristol-Myers Squibb Company 40
Carolus Therapeutics, Inc. 41
Celgene Corporation 42
Chong Kun Dang Pharmaceutical Corp. 43
Compugen Ltd. 44
Corridor Pharmaceuticals Inc. 45
Digna Biotech, S.L. 46
Eli Lilly and Company 47
F. Hoffmann-La Roche Ltd. 48
FibroGen, Inc. 49
Five Prime Therapeutics, Inc. 50
Galectin Therapeutics, Inc. 51
GenKyoTex S.A. 52
Gilead Sciences, Inc. 53
GlaxoSmithKline plc 54
HanAll Biopharma Co., Ltd. 55
Histocell S.L. 56
iBio, Inc. 57
IMMD Inc. 58
ImmuneWorks, LLC 59
IntelGenx Corp. 60
InterMune, Inc. 61
Inventiva SAS 62
Kasiak Research Pvt. Ltd. 63
Kyorin Pharmaceutical Co., Ltd. 64
Lanthio Pharma B.V. 65
Lpath, Inc. 66
LTT Bio-Pharma Co., Ltd. 67
MedImmune, LLC 68
Mesoblast Limited 69
miRagen Therapeutics, Inc. 70
Moerae Matrix, Inc. 71
MSM Protein Technologies, Inc. 72
NicOx S.A. 73
Pacific Therapeutics Ltd. 74
Pharmaxis Limited 75
Pluristem Therapeutics Inc. 76
Progenra, Inc. 77
Promedior, Inc. 78
ProMetic Life Sciences Inc. 79
Pulmatrix, Inc. 80
RestorGenex Corporation 81
Rhizen Pharmaceuticals SA 82
Sanofi 83
Therametrics holding AG 84
Vectura Group plc 85
Pulmonary Fibrosis – Therapeutics Assessment 86
Assessment by Monotherapy Products 86
Assessment by Combination Products 87
Assessment by Target 88
Assessment by Mechanism of Action 92
Assessment by Route of Administration 95
Assessment by Molecule Type 97
Drug Profiles 99
(pentoxifylline + acetylcysteine) – Drug Profile 99
ABC-294640 – Drug Profile 100
AEOL-10150 – Drug Profile 102
AM-0010 – Drug Profile 105
ANG-3070 – Drug Profile 106
ANG-3298 – Drug Profile 107
Antibodies to Inhibit LPA1 for Idiopathic Pulmonary Fibrosis – Drug Profile 108
AQX-1125 – Drug Profile 109
BB-3 – Drug Profile 111
BMS-986020 – Drug Profile 113
BOT-191 – Drug Profile 114
C-301 – Drug Profile 115
CC-539 – Drug Profile 116
CC-90001 – Drug Profile 117
CG-1011 – Drug Profile 118
CGEN-25009 – Drug Profile 119
CKD-942 – Drug Profile 120
CT-140 – Drug Profile 121
CT-2009 – Drug Profile 122
DB-02901 – Drug Profile 123
disitertide – Drug Profile 124
Drug for Idiopathic Pulmonary Fibrosis – Drug Profile 126
Drugs to Antagonize IGF-1 Receptor for Acute Lung Injury and Pulmonary Fibrosis – Drug Profile 127
FG-3019 – Drug Profile 128
FPA-008 – Drug Profile 130
GKT-137831 – Drug Profile 131
GR-MD-02 – Drug Profile 132
HC-016 – Drug Profile 134
HL-156FIB – Drug Profile 135
HR-017 – Drug Profile 136
IBIOCFB-03 – Drug Profile 137
ICG-001 – Drug Profile 138
IMD-1041 – Drug Profile 139
INT-0024 – Drug Profile 140
interferon gamma-1b – Drug Profile 141
ITMN-10534 – Drug Profile 142
ITMN-14440 – Drug Profile 143
ITMN-30162 – Drug Profile 144
IVA-337 – Drug Profile 145
IW-001 – Drug Profile 146
KBP-7018 – Drug Profile 147
lebrikizumab – Drug Profile 148
LP2 – Drug Profile 150
Lpathomab – Drug Profile 151
LT-0011 – Drug Profile 152
LY-2109761 – Drug Profile 153
MGN-4220 – Drug Profile 154
MMI-0100 – Drug Profile 155
Monoclonal Antibody for Idiopathic Pulmonary Fibrosis – Drug Profile 156
MSM-735 – Drug Profile 157
MSX-122 – Drug Profile 158
NAS-911 – Drug Profile 160
NCX-466 – Drug Profile 161
nintedanib – Drug Profile 162
Oligonucleotides for Respiratory and Oncology – Drug Profile 166
omipalisib – Drug Profile 167
P-007 – Drug Profile 168
P-17 – Drug Profile 169
P-529 – Drug Profile 171
PBF-1250 – Drug Profile 173
PBI-4050 – Drug Profile 174
phytate sodium – Drug Profile 175
pirfenidone – Drug Profile 176
PRI-724 – Drug Profile 177
PRM-151 – Drug Profile 179
PUR-1500 – Drug Profile 181
PXS-25 – Drug Profile 182
PXS-4820 – Drug Profile 183
PXS-5033-A – Drug Profile 184
PXS-64 – Drug Profile 185
Recombinant Human Follistatin – Drug Profile 186
Refacell-IPF – Drug Profile 187
RNAi Oligonucleotides for Idiopathic Pulmonary Fibrosis – Drug Profile 188
RP-6503 – Drug Profile 189
SAR-156597 – Drug Profile 190
SD-560 – Drug Profile 191
simtuzumab – Drug Profile 192
Small Molecule 1 for Chronic Respiratory Diseases – Drug Profile 194
Small Molecule 2 for Chronic Respiratory Diseases – Drug Profile 195
Small Molecule to Antagonize Integrin Alpha V for Idiopathic Pulmonary Fibrosis – Drug Profile 196
Small Molecule to Inhibit NOX 1 and 4 – Drug Profile 197
Small Molecules to Antagonize LPA1 Receptor for Pulmonary Fibrosis – Drug Profile 198
Small Molecules to Inhibit LOXL2 for Oncology and Fibrosis – Drug Profile 199
Small Molecules to Inhibit USP34 for Idiopathic Pulmonary Fibrosis – Drug Profile 200
SPL-334 – Drug Profile 201
Stem Cell Therapy for Asthma and Pulmonary Fibrosis – Drug Profile 202
Stem Cell Therapy for Idiopathic Lung Fibrosis – Drug Profile 203
Stem Cell Therapy for Pulmonary Fibrosis – Drug Profile 204
STX-100 – Drug Profile 205
Synthetic Peptides to Antagonize TGF-Beta Receptor for Diabetic Foot Ulcers, Pulmonary Fibrosis and Dermatology – Drug Profile 206
Synthetic Peptides to Inhibit PDE-4A4 for Pulmonary Fibrosis and Nerve Injury – Drug Profile 208
TD-139 – Drug Profile 209
tipelukast – Drug Profile 210
tralokinumab – Drug Profile 212
vismodegib – Drug Profile 214
Pulmonary Fibrosis – Recent Pipeline Updates 217
Pulmonary Fibrosis – Dormant Projects 265
Pulmonary Fibrosis – Discontinued Products 269
Pulmonary Fibrosis – Product Development Milestones 270
Featured News & Press Releases 270
Appendix 280
Methodology 280
Coverage 280
Secondary Research 280
Primary Research 280
Expert Panel Validation 280
Contact Us 281
Disclaimer 281
【レポート販売概要】
■ タイトル:肺線維症(Pulmonary Fibrosis)の治療薬パイプライン動向(2015年上半期版)■ 英文:Pulmonary Fibrosis - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6017IDB
■ 調査対象地域:グローバル
- 世界の海上防衛・国境警備市場:市場規模及びドライバーSummary This report provides readers with a comprehensive analysis of the Maritime and Border Security market through 2013-2023, including highlights of the demand drivers and growth stimulators for Maritime and Border Security. It also provides an insight on the spending pattern and modernization pattern in different regions around the world. Reasons To Buy "The Global Maritime and Border Securit …
- MINT (メキシコ, インドネシア, ナイジェリア,トルコ)の国家防衛支出動向(~2019)Synopsis SDI’s "Homeland Security Expenditure in MINT (Mexico, Indonesia, Nigeria and Turkey) to 2019: Market Review" provides historic and forecast market sizing and budget allocation, and a top-level analysis of the market. Summary SDI’s "Homeland Security Expenditure in MINT (Mexico, Indonesia, Nigeria and Turkey) to 2019: Market Review" provides a quantitative view of historic and forecast mar …
- 電子用接着剤の世界市場:導電性接着剤、熱伝導性接着剤、紫外線硬化型接着剤The global electronic adhesives market size, in terms of value, is projected to reach USD 6,085.4 Million by 2020, at a CAGR of 10.1% between 2015 and 2020. In terms of volume, the global electronic adhesives market is projected to reach 1,916.7 kilotons by 2020, at a CAGR of 5.9% during the forecast period. The increasing number of patents filed for electronic adhesives products & applications by …
- 世界の潜水艦(Submarine)市場動向(2014-2018)TechNavio's analysts forecast the Global Submarine market to grow at a CAGR of 3.27 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased focus and spending on R&D. The Global Submarine market has also been witnessing the leading vendors entering developing countries. However, the cuts in defense budgets across the world could pose a challeng …
- 採鉱装置(鉱山機械)のグローバル市場動向(2014-2018)About Global Mining Equipment Mining equipment is used to extract various minable resources such as metals, coal, and minerals from the earth. Mining companies use mining equipment to extract mined products such as iron ore, titanium, bauxite, and copper; gravels, sand, platinum, gold, coal, and salt; and various non-metallic products. Mining equipment includes trucks, dozers, loaders, borers, coa …
- 軸性脊椎関節炎(Axial SpA)治療薬のグローバル治験動向(2015年上半期)Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015" provides data on the Axial Spondyloarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Axial Spondyloarthritis. It includes an overview of the trial numbers …
- 教育用装置の世界市場:パソコン、タブレット、ディスプレイ、電子黒板、スタイラスペン、ワイヤレススレート、ウェアラブル端末、プロジェクター、サウンド装置About the Global Education Hardware Market Over the years, there has been a significant increase in the adoption of technology in the education sector globally. With an increase in investment by educational institutions to build IT infrastructure, there has been a noteworthy influence on the way education is imparted. As a result, the traditional classroom structure is gradually being replaced by …
- IT運用分析の世界市場:リアルタイムログ解析、アプリケーション・パフォーマンス管理、インフラ管理、ネットワークおよびセキュリティ管理The increasing complexity of traditional IT operations, rise in the number of data centers across the world, and increasing investments in ITOA technologies have increased the adoption rate of IT Operations Analytics (ITOA) solutions, thereby providing immense opportunities to the vendors. These vendors are ultimately helping the organizations yield better analytical results and performance out of …
- 世界のサードパーティーリスク管理(TPRM)市場:コンポーネント別(ソリューション(財務管理、契約、オペレーショナルリスク、監査、コンプライアンス)、サービス(プロフェッショナルおよびマネージド))、展開モード別、組織規模別、業種別、地域別Demand for a seamless experience and personalized services, along with the growing need of organizations to improve operational efficiency across several verticals, is driving the overall growth of the third-party risk management market. The global Third-Party Risk Management (TPRM) market size is projected to grow from USD 3.2 billion in 2019 to USD 6.8 billion by 2024, at a CAGR of 15.9% during …
- 先進複合材料の世界市場予測(~2022年):炭素、Sクラス、アラミド、熱硬化性樹脂、熱可塑性樹脂The advanced composites market is projected to grow from an estimated USD 22.91 Billion in 2017 to USD 38.41 Billion by 2022, at a CAGR of 10.89% between 2017 and 2022. The growth of the advanced composites market can be attributed to increased use of advanced composites in the aerospace & defense, sporting goods, and transportation industries, as these offer a high strength-to-weight ratio and in …
- LTE市場:インフラ別、デバイス別、キャリアサービス別分析(LTE Market by Infrastructure, Devices and Operator Services 2012 – 2016)The growing demand for mobile broadband services is driving an ever increasing number of commercial LTE network deployments. This surge has seen the number of LTE subscriptions already surpass 7 Million subscriptions worldwide, and over 300+ commercial LTE user device launches. As the market gained momentum, the LTE industry witnessed revenues for over $ 19.1 Billion in 2011 alone. Projected to gr …
- 中国のデータセンター市場2016-2020About Data Center Data centers are established by either large-scale enterprises or enterprises offering cloud-based services. Enterprises are building colocation and managed hosting data center facilities and renting them to other large enterprises and SMEs. With the evolution of cloud computing and increased use of big data analytics, more data centers that can cater to the increased computing r …
- 高性能セラミックコーティング剤の世界市場:製品種類別(酸化物コーティング、炭化物コーティング、窒化物コーティング)、技術別(サーマルスプレー、物理蒸着、化学蒸着、およびその他のテクノロジー)、エンドユーズ産業別(自動車、航空宇宙および防衛、一般産業用ツールおよび機械、ヘルスケア、その他)The global high performance ceramic coatings market was valued at $7,844.0 million in 2018 and is projected to reach $12,633.3 million by 2026, growing at a CAGR of 6.2% from 2019 to 2026. High performance ceramic coatings are inorganic materials which are treated and used at high temperatures. These coatings are applied on automotive engine components, which increases the fuel efficiency. Its phy …
- 頭蓋内圧モニタリング装置の世界市場2019-2023104 pages, November 2018 About this market The increase in regulatory approval for products in the healthcare sector had led intracranial pressure monitoring devices industry grow during our forecasted period. The manufacturers are focusing on strengthening their market presence by expanding their product portfolio and also entering new business territories, which will subsequently fuel the growth …
- Japanese Flow Cytometry Market 2014: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive LandscapeComplete report $4,900. DataPack (test volumes, sales forecasts, supplier shares) $3,200.This report presents a comprehensive analysis of the Japanese flow cytometry market, including:Major issues pertaining to the Japanese flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.Five- …